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Atherosclerotic occlusive disease of the renal
artery is a frequent cause of end-stage renal disease
and is estimated to account for approximately 15%
of the patients who require dialysis.1,2 As the pop-
ulation grows older, not only is the number of
patients with atherosclerotic disease of the kidney
gradually increasing but so is the number of
comorbid factors in these patients. This con-
tributes to the grave prognosis of patients with
renovascular disease. Once dialysis treatment has
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Objective: Renovascular disease may lead to ischemia of the nephrons and to fibrosis,
which is generally considered to be irreversible and progressive. We investigated the
potential of revascularization to recover and stabilize renal function in patients with
ischemic nephropathy.
Methods: In a retrospective analysis of all our 61 patients with ischemic nephropathy who
underwent treatment with surgical revascularization, we determined the long-term course
of renal function decline with an estimated glomerular filtration rate (EGFR; Cockcroft
and Gault formula). With the assumption of normal renal function at age 25 years, the
preoperative slope of EGFR and the postoperative slope of EGFR were determined from
the EGFR before surgery, at the short-term follow-up examination (on average, 8 months
after surgery), and at the long-term follow-up examination (on average, at 47 months
after surgery). These declines in renal function were compared with EGFR values in age-
matched and sex-matched samples from a large cross-sectional population study.
Results: The overall surgical mortality rate amounted to 13.1%. Five patients became dial-
ysis dependent—two with preexisting end-stage renal disease and three at later follow-up
examination—and two patients, who before surgery were dialysis dependent, could be
withdrawn from dialysis treatment. Shortly after the operation, the mean EGFR level had
increased from 28.3 to 43.1 mL/min/1.73 m2 (P < .01). The rate of decline in renal
function had decreased from an estimated –2.57 mL/min/1.73 m2/year before surgery
(weighted mean: interquartile range, –2.71 to –1.98) to –0.66 mL/min/1.73 m2/year
(weighted mean: interquartile range, –2.00 to –0.18) in the short-term interval to the
long-term interval, which was even slightly better than the slope of –0.84 mL/min/1.73
m2/year in the age-matched and sex-matched control population.
Conclusion: Surgical revascularization in selected patients with renovascular disease and
ischemic nephropathy restores renal function and makes the average long-term rate of
decline in renal function equal to that of the general population. This indicates that in
most patients a “point-of-no-return” has not yet been passed even though their renal
function is already markedly impaired before surgery. Therefore, in well-selected patients
with ischemic nephropathy, considerable improvement of renal function can be realized.
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started, the estimated 5-year survival rate is only
18%.2
Renal artery stenosis with impaired renal func-
tion, “ischemic nephropathy,” is a progressive dis-
ease, especially when caused by atherosclerosis.2-6
Revascularization procedures have proven to be
effective for the treatment of renovascular hyperten-
sion,8-10 and they may reduce the number of cardio-
vascular complications and increase the life-
expectancy rate.11 However, the beneficial effect of
intervention for ischemic nephropathy is less estab-
lished.12-14 Occasional reports have shown that
withdrawal from dialysis and long-term survival after
revascularization can be obtained in selected
patients.15 Patients with ischemic nephropathy usu-
ally come under medical attention at a relatively late
stage (ie, when severe hypertension and significant
renal function loss are already present). In the case
of a unilateral stenosis, the nonstenotic kidney will
have had hypertensive damage. The impact of long-
term ischemia and of hypertension on the kidneys is
a progressive deterioration of renal function as the
result of the loss of nephrons by sclerosis. Once
fibrosis appears, it is generally considered irreversible
and progressive, even if the underlying cause is treat-
ed.7 This implies that revascularization of stenotic
renal arteries may come too late to recover or even
to retard renal function loss. Therefore, it is impor-
tant to identify more clearly to what extent revascu-
larization allows recovery and stabilization of renal
function in patients with ischemic nephropathy.
In this study, we analyzed the course of renal
function in patients with chronic renal insufficiency
who underwent treatment at our institution for re-
novascular hypertension and ischemic nephropathy
with surgical revascularization. Within the first
months after revascularization, major changes in
renal function may occur as a result of various fac-
tors. Revascularization may recover renal function as
a result of improved renal perfusion, and, on the
other hand, renal function can deteriorate as a result
of complications like cholesterolembolization.
Withdrawal of antihypertensive medication and
changes in hydration state also may have a variable
effect on renal function. Because we were especially
interested to determine whether renal ischemia leads
to irreversible and progressive renal function loss, we
focused our analysis on the long-term postoperative
course in renal function (ie, from, on average, 8 to
47 months after surgery). For each patient, the
course in renal function over time was compared
with age-matched and sex-matched reference values
from a general population, derived from the original
dataset of a large Belgian cross-sectional population
study on nutrition and health.16,17
PATIENTS AND METHODS
Selection of patients
Between 1959 and 1994, 291 patients under-
went treatment of renovascular disease with surgical
reconstruction at the Leiden University Hospital.
From this group, all 61 patients (43 men, 18
women) with a preoperative serum creatinine level
of at least 150 m mol/L (1.75 mg/dL) and absence
of diabetes or other renal disease were arbitrarily
defined as having ischemic nephropathy and select-
ed for further analysis of renal function. The indica-
tion for surgical revascularization was only made on
the basis of the presence of stenosis of one or more
renal arteries or its branches, with at least 70% lumi-
nal reduction on angiography and the presence of
hypertension, either satisfactorily or unsatisfactorily
controlled with antihypertensive medication.
Kidneys that were smaller than 8 cm in length were
considered unsuitable for revascularization, either
with surgery or with percutaneous transluminal
renal angioplasty (PTRA). When PTRA became
available during the 1980s, the procedure became
the first treatment option when a circumscript
nonorificial stenosis in the absence of a severely ath-
erosclerotic aorta was encountered, unless the
patient was considered unsuitable for PTRA by the
intervention radiologist. Patients who underwent
treatment with PTRA were not included in this
study because of the totally different renal and
patient characteristics. However, eight patients
unsuccessfully underwent PTRA for atherosclerosis
and one patient for fibrodysplasia. There was no sig-
nificant difference in renal function between those
patients who did initially undergo treatment with
angioplasty and those who did not.
Follow-up analysis
The patients underwent evaluation before
surgery and at the following three follow-up visits: a
postoperative follow-up examination, a short-term
(ST) follow-up examination, and a long-term (LT)
follow-up examination. Postoperative follow-up
examination was defined as the moment of dis-
charge from the hospital after the revascularization
operation (mean, 17 days). ST was the first follow-
up visit that was at least 3 and not later than 12
months after the operation (mean, 8 months after
surgery). LT was the most recent follow-up visit that
was at least 1 year after the operation (mean, 47
months; range, 1 to 20 years after surgery). At each
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visit, clinical data, blood pressure, medication use,
serum creatinine level, and body weight were regis-
tered and stored in a computerized database, as
reported previously.18
In all patients, hypertensive end organ damage
(ie, funduscopic changes, left ventricular hypertro-
phy, extrarenal atherosclerosis, and deterioration of
renal function) was recorded.19 Left ventricular
hypertrophy was evaluated with electrocardiography
with the Sokolow criteria and the Minnesota
code.20,21 Extrarenal atherosclerosis was defined as
the presence of ischemic heart disease, cerebrovascu-
lar disease, or peripheral vascular disease. All the
patients underwent conventional renal angiography
before surgery and after the operation before the ST
follow-up examination. No new occlusions of renal
arteries were observed. During the LT interval,
angiography, mostly intravenous, was performed in
61% of the patients and no new occlusions were
observed. Because the clinical characteristics of the
patients with atherosclerotic or fibrodysplastic dis-
ease differ in many aspects, their results are reported
and discussed separately.
Analysis of the decline in renal function
The renal function was expressed as the serum
creatinine level and as the estimated glomerular fil-
tration rate (EGFR; mL/min/1.73 m2). The EGFR
was calculated at each visit from the values of serum
creatinine level, age, and body weight, with the
Cockcroft and Gault formula with correction for
gender and body surface area.22 The short-term
effect of the surgical reconstruction on renal func-
tion was evaluated from before surgery to the post-
operative and ST follow-up visits. This evaluation
could be performed on the data of all 61 patients—
55 with atherosclerotic renovascular disease and six
with fibrodysplasia (Fig 1).
The long-term effect of surgical reconstruction
on renal function was evaluated as the rate of change
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Fig 1. Enrollment of patients with renovascular hypertension (RVH) and ischemic nephropathy
(serum creatinine level, 150 m mol/L before surgery). Estimated glomerular filtration rate used
Cockcroft and Gault method22 and was corrected for body surface area. PO, Postoperative follow-up
examination; ST, short-term follow-up examination (on average, 8 months after surgery); LT, long-
term follow-up examination (on average, 47 months after surgery).
in renal function between the ST follow-up visit (on
average, at 8 months after surgery) and the LT fol-
low-up visit (on average, at 47 months after surgery).
The slope of renal function decline between the ST
and LT visits in each individual patient was calculat-
ed as (EGFRST – EGFRLT)/follow-up in years and
was expressed as mL/min/1.73 m2/year. This slope
was compared with the decline in renal function in a
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Fig 2. Course of estimated glomerular filtration rate (EGFR) in the general population.16,17 A,
Patients were men (n = 5657). B, Patients were women (n = 4657). Nonlinear regression analysis
yielded best fits with depicted second order polynomial functions.
A
B
large, cross-sectional population study on nutrition
and health comprising 11,302 individuals from the
Belgian population.16,17 The EGFR in the male or
female reference population at 25 years was derived
from nonlinear, curve-fitting (with a second-order
polynomial function; Fig 2) of all male (n = 5657) or
female (n = 4657) subjects from whom complete
data were available to calculate EGFR. For each indi-
vidual patient, two groups of control subjects of the
same gender were selected from this database: one
with the same age as the patient at the ST follow-up
visit and one with the same age as the patient at the
LT follow-up visit (the average size of these groups
was 107 patients, with a range of 46 to 146 patients).
The median EGFR values of these groups were used
for the determination of the EGFR slope, to compare
with the slope of that particular patient. The preoper-
ative slope of EGFR was arbitrarily defined as the
slope of the EGFR in the sex-matched reference pop-
ulation at 25 years and the patient’s EGFR before
surgery.
Because of the small number of patients with
fibrodysplasia and their remarkable improvements,
their renal function data are presented as mean
EGFR at the different follow-up intervals without
calculation of slopes.
Analysis of the blood pressure response
In the patients with atherosclerosis or fibrodys-
plasia, the blood pressure response was presented as
blood pressure value and number of antihyperten-
sive medication needed to control blood pressure at
the respective follow-up intervals.
Statistical analysis
Data are presented as mean values ± standard
error of the mean, unless otherwise indicated. Rate
of decline in renal function is presented as means
weighted for observation duration with interquartile
range. Student t test for paired samples was used to
evaluate renal function and blood pressure respons-
es within groups. P values of less than .05 were con-
sidered to be statistically significant.
RESULTS
Renal artery stenosis was caused by atherosclero-
sis in 55 patients and by fibrodysplastic disease in six
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Table I. Preoperative clinical characteristics
Cause of lesion Atherosclerosis Fibrodysplasia
No. of patients 55 6
Males 39 (71%) 4 (67%)
Females 16 (29%) 2 (33%)
Patients who were dialysis dependent 2 1
Mean age at time of operation (years) 58.0 26.7
Mean systolic/diastolic blood pressure (mm Hg) 180/104 172/109
Median serum creatinine level (m mol/L) 204 227
Mean EGFR (mL/min/1.73 m2) 28.3 31.7
Median antihypertensive medication (no. of agents) 2.4 2.7
Extrarenal atherosclerosis 39 (71%) 3 (50%)
History of smoking 37 (67%) 3 (50%)
Diabetes mellitus 5 (9%) 0
Left ventricular hypertrophy 37 (67%) 3 (50%)
Hypertensive retinopathy
Grade I 8 (15%) 1 (17%)
Grade II 15 (27%) 2 (33%)
Grade III 11 (20%) 2 (33%)
Grade IV 7 (13%) 1 (17%)
Prior PTRA 8 (15%) 1 (17%)
EGFR, Estimated glomerular filtration rate; PTRA, percutaneous transluminal renal angioplasty.
Table II. Estimated glomerular filtration rate val-
ues in patients with ischemic nephropathy caused
by atherosclerosis
No. of patients* EGFR
Before surgery 53 28.3 ± 1.8
Postoperative interval 43 (38) 43.1 ± 3.1†
Short-term interval 40 (29) 38.5 ± 2.6†
Long-term interval 37 (25) 35.6 ± 2.7
Estimated glomerular filtration rate (EGFR) is presented as mean
± standard error of the mean in mL/min/1.73 m2.
†P < .01 versus before surgery.
*Between parentheses, the number of patients whose conditions
improved.
patients (Fig 1). The clinical characteristics of these
patients are presented in Table I.
Thirty-one patients underwent unilateral recon-
struction in the presence of an angiographically nor-
mal-appearing contralateral renal artery (partial
renal mass revascularized), and 30 patients under-
went either a bilateral reconstruction or a recon-
struction of a solitary kidney (total renal mass revas-
cularized). From the latter group, four had under-
gone a previous nephrectomy and five had
undergone treatment with renal revascularization on
one side combined with contralateral nephrectomy.
Nineteen patients also underwent aorto(iliac) recon-
struction.
Eight patients died during surgery or after
surgery while the patient still was hospitalized. Two
patients became dialysis-dependent immediately
after the intervention. One patient, before the ST
follow-up examination, and three other patients, at
the LT follow-up examination, had end-stage renal
failure develop for which renal replacement therapy
was necessitated. Incomplete or no follow-up data
were available for five patients (Fig 1). Because the
aim of the present analysis was to evaluate the long-
term course of renal function after revascularization,
these patients had to be excluded from the long-
term follow-up analysis.
Renal function
Patients with atherosclerosis: short-term
effect on renal function. At the time of analysis, the
EGFR values could be calculated in 53 patients at the
preoperative examination, in 43 patients at the post-
operative follow-up visit, in 40 patients at the ST fol-
low-upvisit, and in 37 patients at the LT follow-up
visit (Fig 1). The preoperative EGFR level was com-
pared with the EGFR levels both at the postoperative
visit and at the ST follow-up visit for the group of
patients with ischemic nephropathy that was caused
by atherosclerosis (Table II). From the preoperative
visit to the postoperative interval, a significant
increase in mean EGFR level, from 28.3 to 43.1
mL/min/1.73 m2 (P < .01), was observed. Two
patients, who were dialysis independent before
surgery, required chronic dialysis after surgery. These
two patients were first seen with acute renal insuffi-
ciency. One was already anuric for 1 week before the
operation and had an EGFR of 3.3 mL/min/1.73
m2, and the other patient, with an EGFR of 4.1
mL/min/1.73 m2, had an acute occlusion of the
renal artery of a single functioning kidney at PTRA.
Although the patients had normal-sized kidneys, the
surgical treatment remained unsuccessful. The results
observed in younger patients were superior to those
observed in older patients. The age of the patients
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Fig 3. Course of estimated glomerular filtration rate (EGFR) between short-term (average, 8 months
after surgery) and long-term (average, 47 months after surgery) follow-up examinations in all 37
patients with atherosclerotic renovascular disease. Continuous lines represent men, and dashed lines rep-
resent women. Upper two curves represent estimated course of EGFR in the general population (Fig 2).
was inversely related to the increase in EGFR after
the operation (r = 0.36; P < .05). Other preoperative
factors, such as hypertension, smoking history, and
presence of extrarenal atherosclerosis or other
comorbid conditions, did not correlate with the renal
function response. At the ST follow-up examination,
the beneficial effect of the revascularization was well
maintained with an EGFR of 38.5 mL/min/1.73 m2
(Table II; P < .01).
Patients with atherosclerosis: long-term
effect on renal function. The individual EGFR lev-
els at the ST and LT follow-up visits are depicted in
Fig 3. Also presented in this figure is the decline of
renal function in the male and female (Fig 2) control
population.16,17
At the time of analysis, two patients at the LT
follow-up examination required hemodialysis be-
cause of end-stage renal failure. These two patients
are included in the results and in Fig 3.
A typical example of the quantitative analysis of
the rate of change in renal function is shown in Fig
4. From 25 years of age, as estimated from the
EGFR at 25 years in the control population, until
before surgery, the slope of EGFR was –2.57
mL/min/1.73 m2/year (weighted mean: interquar-
tile range, –2.71 to –1.98). Between the ST and LT
intervals, the slope was –0.66 mL/min/1.73
m2/year (weighted mean: interquartile range, –2.00
to 0.18; P < .01 vs before surgery) in the 37
patients, and, in the age-matched and sex-matched
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 6 van Rooden et al 1043
Fig 4. Typical example of analysis, in male patient, of effect of revascularization on renal func-
tion decline. Decline in renal function in male control population16,17 is depicted by thick-line
curve (Fig 2A). From before surgery until short-term (ST; in this case, 8 months after surgery)
follow-up visit, estimated glomerular filtration rate (EGFR)22 improved significantly. Decline
in renal function between short-term and long-term (LT; in this case, 90 months later) follow-
up visit is depicted by slope (–0.8 mL/min/1.73 m2/year) of line connecting short-term and
long-term points. In control population, decline over same interval (arrows) is depicted by line
c (–1.1 mL/min/1.73 m2/year). Preoperative decline in renal function (assuming that patient
had a normal renal function at age of 25 years) is arbitrarily chosen as line connecting EGFR
at 25 years of age in normal male control population and EGFR before surgery (short-dashed
line; –2.1 mL/min/1.73 m2/year). Self evidently, actual preoperative course of renal function
in a patient is, in fact, unknown and more likely first follows normal population curve and, in
the last years before revascularization, shows a more rapid decline when renal artery stenoses
or hypertensive renal damage becomes critical (for example, as depicted by curve a).
control population, the slope of renal function
decline was –0.84 mL/min/1.73 m2/year (weight-
ed mean: interquartile range, –0.91 to –0.82; not
significantly different as compared with the ST-LT
slope in the patients; Fig 5).
Patients with atherosclerosis: partial versus
total revascularization. When the revascularized
amount of renal mass was considered (ie, partial ver-
sus total renal mass revascularized), both groups had
a significant increase in mean EGFR level at the
postoperative follow-up visit (Table III; P < .01). As
a result of differences in duration of ST and LT fol-
low-up, the beneficial effects of intervention seem to
be maintained only in those patients who submitted
to total renal mass reconstruction (Table III; P < .01).
However, the course was not different between the
patients with total renal mass revascularized (–0.85 ±
0.71 mL/min/1.73 m2/year) as compared with the
patients with partial renal mass revascularized (–1.12
± 0.55 mL/min/1.73 m2/year; P > .05).
Patients with fibrodysplasia. EGFR values
could be calculated in six patients at the preopera-
tive, postoperative, and ST follow-up visits and in
five patients at the LT follow-up visit because of
missing data in one patient. A remarkable beneficial
effect of reconstruction was already present at the
postoperative follow-up examination (P < .05). The
renal function even further improved up to the LT
follow-up examination (Table IV; P < .01). The
results of intervention in this group were superior to
those results in the atherosclerotic group at all the
follow-up intervals (P < .05).
Blood pressure
Patients with atherosclerosis. The effect of
reconstructive surgery on the blood pressure in
patients with atherosclerosis is summarized in Table
V. A significant drop (P < .01) in the mean blood
pressure level could already be observed immediate-
ly after the operation (postoperative interval). This
reduction was maintained at the ST and LT follow-
up visits (P < .01). The number of antihypertensive
agents could be significantly reduced after the oper-
ation at all three postoperative follow-up intervals
(Table V: P < .01).
Patients with fibrodysplasia. At all three post-
operative follow-up visits, a reduction in blood pres-
sure and antihypertensive medication was present
(Table VI; P < .05). At ST and LT follow-up visits,
all the patients were normotensive without antihy-
pertensive medication.
DISCUSSION
The main objective of this study was to identify
to what extent surgical revascularization allowed sta-
bilization and recovery of renal function in patients
with ischemic nephropathy. Our study clearly
demonstrated that renal artery reconstruction in
selected patients with ischemic nephropathy had a
significant immediate and long-term beneficial effect
on renal function.
As far as we know, the course of renal function in
patients has never been compared with the course in
control subjects. We used age-matched and sex-
matched control subjects obtained from the original
database, which contained length, body weight,
gender, and serum creatinine level values, of a large
population study on nutrition and health, compris-
ing 11,302 individuals.16,17 The latter study was
performed approximately in the middle of our study
period, in a neighboring country in which the racial
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Fig 5. Slope of estimated glomerular filtration rate (EGFR;
weighted means with interquartile ranges) before (open
bar) and after operation (hatched bar; P < .01 vs before
operation) and in a control population (black bar). With
assumption of normal renal function at age 25 years, pre-
operative slope of EGFR in each patient was arbitrarily
defined as slope between EGFR in sex-matched control
population at 25 years and patient’s preoperative EGFR.
Long-term slope of EGFR after operation was calculated for
each of the 37 patients as slope between each individual’s
EGFR at short-term and long-term follow-up visits. Slope
in the control population was derived by taking for each
patient at short-term and at long-term follow-up visits
EGFR in age-matched and sex-matched control population.
distribution and average life expectancy were identi-
cal. Although these control subjects were part of a
cross-sectional, rather than a longitudinal, follow-up
study, the size, the similar background of the popu-
lation, and the availability of the original individual
data make an excellent comparison possible.
Moreover, one can argue that, entirely by the large
numbers, the averages per age category of a cross-
sectional study must come close to what a longitudi-
nal follow-up study would yield as the average
course of renal function versus age. From this gen-
eral population study, it became possible to extract
large age-matched and sex-matched samples as con-
trol subjects for each patient at each follow-up visit
and to use the Cockcroft and Gault approximation
of glomerular filtration rate for further analysis,22,23
with actual serum creatinine level and body weight
at the time of follow-up examination and corrected
for body surface area. Although this formula has its
limitations, it accurately reflects the gold standard
(ie, the urinary insulin clearance) at estimated crea-
tinine clearances between 20 and 100 mL/min/
1.73 m2.24 Many other studies have used serum cre-
atinine level as the main outcome parameter, often
presented as averaged percent changes over time or
classified as “improved,” “stable,” or “deteriorated.”
Obviously, such methods do not allow the analysis of
the individual course of renal function and cannot
determine to what extent a therapeutic intervention
has restored the natural decline in renal function in
individual patients. Because recovery of renal func-
tion after revascularization can take many months
and because we specifically wanted to evaluate the
long-term course of renal function, we chose a time
interval of at least 3, up to a maximum of 12,
months after surgery before the long-term follow-up
evaluation period started.
The effect of revascularization was most out-
spoken in our small subgroup of patients with
fibrodysplastic disease. In fact, these patients could
be considered as practically cured. In these young
patients with fibrodysplastic lesions and impaired
renal function, the indication for intervention was
not difficult. However, in older patients with ath-
erosclerotic disease, retrieval was more uncertain.
Often, comorbid conditions, such as ischemic heart
disease, diabetes, and extrarenal atherosclerosis,
were present. These patients usually had a signifi-
cant increased operative risk, which was also shown
by our surgical mortality rate of 13%. Preoperative
parameters that help to predict the perioperative
morbidity rate, like co-morbid conditions, older
age, and more extensive surgical interventions, are
well known. However, preoperative parameters
that help to predict the postoperative success of
surgery in ischemic nephropathy (ie, restoration of
renal function) are largely unknown. In this study,
only age at operation correlated, inversely, with
renal function outcome.
Part of the immediate beneficial effect of surgical
revascularization on the renal function response may
be attributed to the withdrawal of antihypertensive
medication after operation. Several antihypertensive
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Table III. Estimated glomerular filtration rate in patients with atherosclerosis according to the amount of
revascularized renal mass
Partial renal mass Total renal mass
No. of patients EGFR No. of patients EGFR
Before surgery 28 29.1 ± 2.6 25 27.3 ± 2.7
Postoperative interval 24 42.3 ± 4.7* 19 44.0 ± 3.8*
Short-term interval 22 35.8 ± 3.4 18 41.7 ± 3.9*
Long-term interval 21 31.9 ± 3.4 16 40.5 ± 4.1*
Estimated glomerular filtration rate (EGFR) is presented as mean ± standard error of the mean in mL/min/1.73 m2.
*P < .01 versus before surgery.
Table IV. Estimated glomerular filtration rate in
patients with ischemic nephropathy secondary to
fibrodysplasia
No. of patients* EGFR
Before surgery 6 31.7 ± 3.1
Postoperative interval 6 (6) 83.9 ± 11.6†
Short-term interval 6 (6) 88.6 ± 10.2†
Long-term interval§ 5 (5) 92.3 ± 11.0‡
Estimated glomerular filtration rate (EGFR) is presented as mean
± standard error of the mean in mL/min/1.73 m2.
*Between parentheses, the number of patients whose conditions
improved.
†P < .05.
‡P < .01 versus before surgery.
§At this interval, six patients were available, but incomplete data
were available from one of these patients. 
drugs may diminish renal function in ischemic
nephropathy,25-29 but particular angiotensin-con-
verting enzyme inhibitors are a well known cause of
deterioration of renal function29-33 and even may
induce renal artery occlusion.34,35 In our patients,
blood pressure and antihypertensive medication
were immediately reduced after intervention. For
example, before the operation, 18% of our patients
were undergoing angiotensin-converting enzyme
inhibitor therapy, whereas at the postoperative and
ST follow-up intervals these rates were 6%.
Renal vascular disease caused by atherosclerosis is
clearly a progressive disease. Without intervention,
most of our patients would probably have required
dialysis treatment within approximately 8 years.
Operation retrieved and stabilized renal function to
such an extent that the need for renal replacement
therapy was significantly delayed, as can be deduct-
ed from the improvement in the long-term rate of
decline in renal function. In fact, two patients who
were dialysis dependent before surgery had condi-
tions that were markedly improved and could be
withdrawn from dialysis treatment at the immediate
postoperative period until the last, long-term follow-
up examination. Other studies also showed that
revascularization in selected patients successfully
withdrew them from hemodialysis.13,36-39
Clearly, surgical intervention for ischemic
nephropathy cannot always be successful. Directly
after operation, two of our patients became dialysis
dependent. Both patients had kidneys of at least 8
cm in length, but one patient was already anuric for
1 week before the operation and had an EGFR of
3.3 mL/min/1.73 m2 and the other patient, with
an EGFR of 4.1 mL/min/1.73 m2, had an acute
occlusion of the renal artery of a single functioning
kidney at PTRA. In both patients, the operation was
technically a success, as determined with angiogra-
phy, but renal function did not recover. During the
follow-up period, three additional patients (with
preoperative EGFRs of 13, 28, and 32 mL/min/
1.73 m2) were started on renal replacement therapy.
Hallett et al40 reported, at a mean follow-up visit of
17.5 months, a need for dialysis treatment in 9.0% of
a group of 174 patients with renovascular hyperten-
sion and preoperative serum creatinine values
between 2 and 3 mg%, which is similar to the 8.2%
in our patients, however, at a mean follow-up dura-
tion of 47 months. In patients with preoperative
serum creatinine levels of more than 3 mg%, Hallett
et al40 reported that, again at a mean follow-up peri-
od of 17.5 months, 35% of these patients needed
chronic dialysis treatment. Therefore, we think that
one should be reluctant in performing reconstruc-
tive interventions in patients with severe renal insuf-
ficiency, unless firm evidence for the viability of their
kidneys has been obtained.
Patients with renal artery stenosis usually have
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Table V. Blood pressure and antihypertensive medication requirement of the patients with ischemic
nephropathy caused by atherosclerosis
Medication requirement
No. of patients Blood pressure (mm Hg) (no. of drugs)
Before surgery 55 180/104 ± 4/2 2.4 ± 0.1
Postoperative interval 45 153/89 ± 3/1* 0.9 ± 0.2*
Short-term interval 42 161/91 ± 5/2* 1.2 ± 0.2*
Long-term interval 41 154/88 ± 4/2* 1.7 ± 0.2*
Data are presented as mean ± standard error of the mean.
*P < .01 versus before surgery.
Table VI. Blood pressure and antihypertensive medication requirement of the patients with ischemic
nephropathy caused by fibrodysplasia
Medication requirement
No. of patients Blood pressure (mm Hg) (no. of drugs)
Before surgery 6 172/109 ± 5/5 2.7 ± 0.3
Postoperative interval 6 144/89 ± 8/4* 0.5 ± 0.2*
Short-term interval 6 128/81 ± 5/3* 0*
Long-term interval 6 126/80 ± 4/3* 0*
Data are presented as mean ± standard error of the mean. 
*P < .05 versus before surgery.
severe forms of systemic hypertension that may
induce hypertensive renal damage in the nonstenot-
ic part of the kidney. In an experimental study,
Truong et al41 indeed observed, besides tubuloint-
erstitial changes in the stenotic kidney, focal changes
caused by hypertensive vascular damage in the non-
stenotic kidney. Analysis of living related kidney
donations shows that renal insufficiency after
nephrectomy does not develop in normotensive
healthy persons.42 Therefore, to account for the sig-
nificant loss of renal function at the preoperative
interval in patients with unilateral disease, it seems
that hypertensive nephropathy in the contralateral
kidney must have taken place. Histologically, renal
ischemia and hypertensive renal damage cannot be
easily differentiated from each other because of over-
lapping features. Renal ischemia is characterized by
glomerular capillary collapse, localized glomerular
sclerosis, reduplication of the glomerular basement
membrane, mesangial expansion, and localized areas
of interstitial inflammation and fibrosis, and more
characteristic features of hypertensive renal damage
are glomerulosclerosis and arteriolosclerosis.41,43 A
number of factors may contribute or trigger the
process that results in ischemic nephropathy.7 With
moderate renal artery stenosis, the ischemic kidney
may be relatively protected against further, hyper-
tensive damage and may longer keep the ability to
regain function when revascularized. At some stage
of renal ischemia, however, irreversible damage with
progressive renal fibrosis that cannot be interrupted
by renal revascularization is likely to develop.
In our patients, the calculated slope of renal
function decline before surgery was –2.51 ± 0.20
mL/min/1.73 m2/year, and, from the ST to the LT
follow-up visit, it had decreased to –1.00 ± 0.43
mL/min/1.73 m2/year, which appeared even
slightly better than the slope in age-matched and
sex-matched control individuals of –1.13 ± 0.02
mL/min/1.73 m2/year. This shows that, in patients
with renovascular disease, the average decline in
renal function can be restored towards a normal
course with surgical revascularization and indicates
that, in most of our patients, a “point-of-no-return”
had not yet been passed, although their renal func-
tion was already markedly impaired before surgery.
This becomes even more meaningful if we consider
that our estimate of preoperative renal function
slope is likely to be optimistic because we took the
EGFR in the reference population at 25 years and
the EGFR of our patients before surgery for preop-
erative slope estimate. In fact, it is not known at
what moment the renal function in a patient with
ischemic nephropathy actually starts to decline faster
than in the general population. Only two other stud-
ies evaluated the rate of decline in renal function.
Chaikof et al14 evaluated retrospectively the long-
term course (from directly after surgery until a medi-
an of 47 months later) of renal function in patients
with ischemic nephropathy and observed a mean
slope of –1.44 mL/min/1.73 m2/year, which cor-
roborates our findings. Dean et al6 analyzed the
postoperative rate of decline in 32 (of 50) patients
during the first 12 months after surgery and
observed a beneficial renal function response in 24
patients. Both studies did not relate their results of
renal function decline to a control population and
therefore cannot identify to what extent revascular-
ization stabilizes renal function in patients with
ischemic nephropathy.
The more recently introduced PTRA has become
the preferred choice of treatment because it is much
less invasive than surgery. The overall results with
respect to renal function, however, seem less favor-
able,9,44,45 and the often present, severe atheroscle-
rotic disease of the aorta and large vessels, the origo-
type of renal artery stenoses, and the failures of
PTRA make surgical revascularization still a fre-
quently needed method. In fact, eight of our patients
had undergone a previous, unsuccessful PTRA.
In conclusion, marked beneficial results can be
obtained with reconstruction of renovascular
stenoses for retrieving and preserving renal function
in patients with ischemic nephropathy. The average
long-term rate of decline in renal function even
becomes equal to the slope in the general popula-
tion. Therefore, in well-selected patients with
ischemic nephropathy, considerable improvement of
renal function can be realized. However, individual
results are heterogeneous and widespread individual
variations in the postoperative course in renal func-
tion are obviously inherent to the difficulty of
patient selection.
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